American Gene Technologies ("AGT") is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including large and orphan indications, infectious disease, immune-oncology, and monogenic disorders.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/03/2021 | Series F-1 | $18MM | $xx.xx | $712.6MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,500,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Undisclosed Investors
|
||||||
04/15/2021 | Series E-1 | $32.5MM | $xx.xx | $289.42MM | Gaingels | |
Price per Share
$xx.xx
Shares Outstanding
6,500,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Gaingels
|
||||||
02/20/2018 | Series D-1 | $15.03MM | $xx.xx | $142.47MM | Alumni Ventures Group, National Institutes Of Health | |
Price per Share
$xx.xx
Shares Outstanding
5,010,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Alumni Ventures Group, National Institutes Of Health
|
||||||
10/30/2015 | Series C-1 | $4.35MM | $xx.xx | $55.42MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,900,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Undisclosed Investors
|
||||||
09/24/2014 | Series B-1 | $2MM | $xx.xx | $15.21MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,166,666
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Undisclosed Investors
|
||||||
09/03/2013 | Series A-1 | $1,000,000.00 | $xx.xx | $4MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,170,610
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Undisclosed Investors
|